Abits
ABTS
Digihost Technology
DGHI
CATHEDRA BITCOIN INC
CBTTF
SATO TECHNOLOGIES CORP
CCPUF
Intchains Group
ICG
CG Oncology, Inc. is a clinical biopharmaceutical company, which engages in the development and commercialization of bladder-sparing therapeutic for patients afflicted with bladder cancer. It offers cretostimogene, a product initially in clinical development for the treatment of patients with Non-Muscle Invasive Bladder Cancer (NMIBC). The company was founded by Alex Yeung and Paul A. DeRidder on September 24, 2010 and is headquartered in Irvine, CA.